- Home
- SNDL vs AMRN Comparison
SNDL vs AMRN Comparison
Compare SNDL & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDL | AMRN |
|---|---|---|
| Founded | 2006 | 1989 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.4M | 342.8M |
| IPO Year | 2019 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SNDL | AMRN |
|---|---|---|
| Price | $1.27 | $14.17 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.9M | 47.2K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $6.19 | N/A |
| Revenue Next Year | $3.08 | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $1.17 | $12.96 |
| 52 Week High | $2.89 | $20.90 |
Technical Indicators
Market Signals| Indicator | SNDL | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.14 | 45.77 |
| Support Level | $1.17 | $14.02 |
| Resistance Level | $1.37 | $14.55 |
| Average True Range (ATR) | 0.06 | 0.43 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 50.00 | 58.22 |
Price Performance
Historical ComparisonAbout SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.